Express Pharma
Home  »  Pharma Ally  »  Ashland aids pharmaceutical manufacturers with formulation services

Ashland aids pharmaceutical manufacturers with formulation services

4

Company showcases pharmaceutical formulation services at CPhI India

Pharmaceutical scientists at Ashland were present during CPhI India to explain how Ashland is providing formulation services to manufacturers in the region that require assistance in tailoring polymer-based drug delivery systems for optimal bioavailability, stability and patient compliance.

“The pharmaceutical market in India is now the third largest in the world,” said Nelson Corda, General Manager, Rest of Asia, Ashland Specialty Ingredients. “Last year, Ashland opened a pharma center of excellence in Hyderabad to conduct oral solid-dosage form research and to assist manufacturers with novel therapeutics through polymeric drug delivery systems. With this facility, we recognise the importance and vitality of the Asia Pacific pharma market and the particular relevance of India within this market.”

Ashland showcased a series of polymer excipients that enable manufacturers of oral dosage forms to produce finished products with relative ease and efficiency. Among the products on display will be Klucel hydroxypropyl cellulose (HPC), a premier tablet binder that makes tablet preparation easy. Polyplasdone crospovidone, a super disintegrant for immediate-release oral dosage forms, will be presented as a core technology proven to enhance dissolution.

Natrosol hydroxyethylcellulose (HEC), a non-ionic water-soluble cellulose ether, will be spotlighted as a technology to control the rheology of solutions and gels. AquaSolve hypromellose acetate succinate (HPMCAS), a solid dispersion polymer, will be presented as a novel technology for bioavailability enhancement of poorly soluble active pharma ingredients. Direct compression grades of Benecel hypromellose will be offered as a technology to control the release of complex drug molecules in solid-dosage forms.

“Ashland brings to India an unparalleled excipient portfolio and a global research and development (R&D) team focused on all of the major formulation trends,” said Thomas Durig, Senior Director, Pharmaceutical and Nutrition Specialties R&D, Ashland Specialty Ingredients.

EP News BureauMumbai

Comments are closed.